CANTON, Mass., June 17 /PRNewswire/ -- Novus Scientific, Inc. today announced the US sales launch of TIGR™ Matrix Surgical Mesh at the Abdominal Wall Reconstruction meeting, Washington DC. In February 2010, the US Food and Drug Administration (FDA) cleared, TIGR™ Matrix Surgical Mesh for use in reinforcement of soft tissues where weakness exists.
"The TIGR™ prosthetic adds a tool to the surgeon's armamentarium that is currently missing – a long acting, synthetic, absorbable product that may not only be beneficial in hernia patients, but also for prophylaxis, potentially preventing the hernia from ever forming in the first place," said David Earle MD FACS, Assistant Professor of Surgery, Tufts University School of Medicine, Springfield, MA.
TIGR™ Matrix Surgical Mesh is knitted from two different resorbable fibers that degrade at different rates following implantation. This unique patented dual-fibre design provides an initial high strength / high stability configuration, with gradually increasing compliance over time as the device is resorbed. The macroporous structure is designed to allow tissue integration for reliable tissue repair.
"TIGR™ Matrix Surgical Mesh begins a new era in patient treatment. While there is a wide range of potential applications for such a unique product, at today's Abdominal Wall Reconstruction meeting there has been particular interest in use of TIGR™ Matrix for onlay or sublay reinforcement in conjunction with the component separation technique," said Jim Archetto, President of Novus Scientific, Inc.
"TIGR™ Matrix Surgical Mesh fills a gap between traditional permanent mesh and biologic prosthetics. This long-term resorbable synthetic mesh defines a new product category that has never existed before, and I see many potential applications for it," stated Karl Leblanc, MD, past president of the American Hernia Society.
About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices. Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden. The company's roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered near Boston, one of the world's foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR™ Matrix Surgical Mesh throughout the United States, Canada, and Latin America.
TIGR™ is a trademark of Novus Scientific Pte Ltd
Contact: JIm Archetto, +1-781-577-2599, firstname.lastname@example.org
SOURCE Novus Scientific, Inc.